Anixa Biosciences, Inc. (ANIX)
NASDAQ·Healthcare·Biotechnology
$2.62
+5.65%
Mkt Cap $99.47M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$5.83
Range $3.50 – $10.00
Implied Upside
+122.9%
Consensus $5.83 vs current $2.62
NASDAQ·Healthcare·Biotechnology
$2.62
+5.65%
Mkt Cap $99.47M
No recent rating data.
Price Target (3 analysts)
$5.83
Range $3.50 – $10.00
+122.9%
Consensus $5.83 vs current $2.62